Etiological DiagnOsis of caRdiac Diseases Based on echoCardiograpHIc Images and Clinical Data.
Launched by HOSPICES CIVILS DE LYON · Jul 4, 2023
Trial Information
Current as of July 09, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how to better diagnose heart diseases using echocardiograms, which are special ultrasound tests that create images of the heart. Researchers believe that these images contain valuable information that can help identify different heart conditions more accurately when combined with other patient data. The goal is to develop advanced digital tools that can automatically predict heart diseases based on the detailed analysis of these echocardiograms.
To participate in this trial, individuals aged 65 and older who have had a transthoracic echocardiogram with good image quality may be eligible. Unfortunately, younger individuals and those under legal guardianship cannot take part. If you join the study, you can expect to contribute to important research that aims to improve heart disease diagnosis using the latest technology. Your participation could help create better tools for doctors to understand heart health and potentially lead to better treatment options in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients with transthoracic echocardiography with satisfactory image quality (sufficient echogenicity)
- Exclusion Criteria:
- • Minor patients
- • Patients under curatorship or guardianship
About Hospices Civils De Lyon
Hospices Civils de Lyon (HCL) is a leading public health institution in France, dedicated to providing high-quality healthcare and advancing medical research. With a rich history dating back to the 18th century, HCL encompasses multiple hospitals and offers a diverse range of services across various medical specialties. The institution is committed to fostering innovative clinical trials that aim to enhance patient care and improve therapeutic outcomes. By collaborating with academic and industry partners, HCL plays a pivotal role in the development of new treatments and the advancement of medical knowledge, ensuring that research efforts are aligned with the highest ethical standards and patient safety protocols.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Pierre Bénite, , France
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported